Brendan Browne
Urology · Atlanta, GANPI 1063772770
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $43,450 of the $52,517 with a category attached, or 82.7%. Cook Incorporated accounts for 94.2% of it on its own, with 6 other manufacturers making up the rest. Among urology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $972.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$49K
- Cook Medical LLC$3K
- Boston Scientific$303
- Procept Biorobotics Corporation$95
- Histosonics, Inc.$33
- Endo Pharmaceuticals Inc.$22
- plus $4 from 1 others
What the payments were for
- Consulting fees$4,1858%
- Speaking & faculty fees$43,45083%
- Travel & lodging$2,5345%
- Food & beverage$2,3444%
- Education$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 15 | $49,466 |
| Cook Medical LLC | 31 | $2,593 |
| Boston Scientific | 4 | $303 |
| Procept Biorobotics Corporation | 1 | $95 |
| Histosonics, Inc. | 1 | $33 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cook$25,243
- LITHO 150$17,253
- FIBER DUST$3,353
- GENERAL BPH$134
- LithoVue$126
- RESONANCE$111
How this compares
$52,517 in reported general payments places this provider in the 95th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 71 | $49,272 |
| GemtesaVibegron | 19 | $18,458 |
| Tamsulosin Hcl | 339 | $5,064 |
| Trospium Chloride ErTrospium Chloride | 14 | $3,184 |
| Methenamine Hippurate | 34 | $2,727 |
| Estradiol | 17 | $2,357 |
| Finasteride | 193 | $1,950 |
| Testosterone | 11 | $1,211 |
| Trospium Chloride | 11 | $1,091 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 34 | $819 |
| Dutasteride | 13 | $599 |
| Testosterone Cypionate | 12 | $531 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 35 | $482 |
| Tolterodine Tartrate | 16 | $307 |
| Oxybutynin Chloride ErOxybutynin Chloride | 24 | $265 |
Paid to pharmacies, not to this prescriber.
Other urology in Atlanta
- Tariq HakkyAtlanta$140K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
- Matthew SandAtlanta$77K
- Rajesh LaunganiAtlanta$33K
- Vikram NarayanAtlanta$29K
- Gregory MitchellAtlanta$15K
- Charles LorentzAtlanta$14K
- Vahan KassabianRoswell$1.6M
- Lewis KritemanRoswell$864K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.